U.S. Markets closed

Timing is Crucial, Upside Analysis - Analyst Notes on Mercury Systems, Synthetic Biologics, CRA International and Altisource Asset Management

NEW YORK, NY / ACCESSWIRE / December 15, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Mercury Systems Inc (MRCY), Synthetic Biologics Inc (SYN), CRA International Inc. (CRAI) and Altisource Asset Management Corp (AAMC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

MRCY Research Package: http://www.traders-choice.com/pdf?s=MRCY

SYN Research Package: http://www.traders-choice.com/pdf?s=SYN

CRAI Research Package: http://www.traders-choice.com/pdf?s=CRAI

AAMC Research Package: http://www.traders-choice.com/pdf?s=AAMC

============

Highlights from today's reports include:

On Monday, December 14, 2015, NASDAQ composite ended at 4,952.23, up 0.38%, Dow Jones Industrial Average advanced 0.60%, to finish the day at 17,368.50, and the S&P 500 closed at 2,021.94, up 0.48%.

- Mercury Systems Inc.'s stock edged lower by 2.01% to close Monday's session at USD 18.56. The company's shares oscillated between USD 18.38 and USD 19.44. The stock recorded a trading volume of 0.13 million shares, which was below its 50-day daily average volume of 0.15 million shares. Over the last three days, Mercury Systems Inc.'s shares have declined by 4.87% and in the past one week the stock has moved down 5.83%. Furthermore, over the last three months, the stock has gained 19.20% and in the past six months, the shares have picked up 31.54%. On a compounded total return basis, the company has returned 42.11% in the past one year. Further, the company is trading at a price to earnings ratio of 51.56 and the stock is at a price to book ratio of 1.77. This compares to a historical PE ratio of 33.42. The historical PB ratio is near to 1.36. Additionally, the stock is trading at a price to cash flow ratio of 18.93 and at a price to sales ratio of 2.75.

- The stock of Synthetic Biologics Inc. lost 7.26% to close Monday's session at USD 2.17. The shares of the company moved in the range of USD 2.15 and USD 2.36. A trading volume of 1.10 million shares was recorded, which was lower than its 150-day daily average volume of 1.49 million shares and below its 52-week average volume of 1.32 million shares. The stock is having 52-week range of USD 1.39- USD 4.32. Over the last five days, Synthetic Biologics Inc.'s shares have declined by 15.89% and in the past one month, the stock has lost 6.06%. Additionally, over the last three months, the stock has declined 21.09% while year to date, the shares have gained 48.63%. On a compounded total return basis, the company has returned 49.66% in the past one year. The stock is at Relative Strength Index of 36.66.

- CRA International Inc.'s stock declined 3.55% to close Monday's session at USD 18.73. The share price vacillated between USD 18.73 and USD 19.82 marking a new 52-week low during the session. The stock recorded a trading volume of 0.12 million shares, which was above its 50-day daily average volume of 0.04 million shares and above its 52-week average volume of 0.05 million shares. Over the last three days CRA International Inc.'s shares have declined by 7.60% and in the past one week the stock has moved down 8.99%. Moreover, in the last six months, the stock has lost 33.15% and year to date, the shares have shed 38.23%. Further, the company is trading at a price to earnings ratio of 13.72 and the stock is at a price to book ratio of 0.80. This compares to a historical PE ratio of 22.03. The historical PB ratio is near to 1.31. Additionally, the stock is trading at a price to cash flow ratio of 6.18 and at a price to sales ratio of 0.56.

- Altisource Asset Management Corp's stock slipped by 8.55% to close Monday's session at USD 11.34. The company's shares oscillated between USD 10.37 and USD 12.41 marking a new 52-week low during the session. The stock recorded a trading volume of 0.21 million shares, which was above its 50-day daily average volume of 0.03 million shares and above its 52-week average volume of 0.02 million shares. Over the last five days, Altisource Asset Management Corp's shares have declined by 18.30% and in the past one month, the stock has lost 45.35%. In addition, over the last three months, the stock has lost 56.43%. Further, the company is trading at a price to earnings ratio of 1.16. This compares to a historical PE ratio of 14.72. Further, the stock is having a 52-week range of USD 10.37- USD 485.06.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice